Search
for
Sort by
Research 481–510 of 1000+
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men
- Androgens and Antiandrogens influence on COVID-19 disease in men
- Germacrene Analogs are Anti-androgenic on Androgen-dependent Cells
- Is there a relationship between androgenic alopecia and benign prostatic hyperplasia?
- 5ARIs and PSA: Evidences
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Novel Missense Mutation in the P-Box of Androgen Receptor in a Patient with Androgen Insensitivity Syndrome
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- GYNECOMASTIA AFTER FINASTERIDE THERAPY
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- The role of 5-alpha-reductase inhibitors in active surveillance
- Primärprävention urologischer Tumore: Prostatakarzinom
- Preparation of3H-labelled testosterone metabolites
- The search for bioactive compounds in tropical plants to target hormone imbalance associated diseases
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Crystal Structure and Synthesis of 17α-Hexanoyloxy-16β-methylpregna-4,6-diene-3,20-dione
- Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial
- Experimental Evaluation of 3-meta-Pyridine-1,2,4-Oxadiazole Derivative of Deoxycholic Acid as a Prototype of 5-α-Reductase Inhibitors in In Silico and In Vivo Models
- Allosteric interactions prime androgen receptor dimerization and activation
- Features of hyperandrogenism in men